Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Tailored cell sheet engineering using microstereolithography and electrochemical cell transfer.

Kobayashi Y, Cordonier CEJ, Noda Y, Nagase F, Enomoto J, Kageyama T, Honma H, Maruo S, Fukuda J.

Sci Rep. 2019 Jul 18;9(1):10415. doi: 10.1038/s41598-019-46801-9.

2.

Preparation of hair beads and hair follicle germs for regenerative medicine.

Kageyama T, Yan L, Shimizu A, Maruo S, Fukuda J.

Biomaterials. 2019 Aug;212:55-63. doi: 10.1016/j.biomaterials.2019.05.003. Epub 2019 May 9.

3.

Effects of triple-treatment trunk stretching on physical fitness and curvature of the spine.

Wakimoto K, Dakeshita T, Wakimoto J, Watanabe T, Terasawa S, Okuhara M, Murata Y, Taki N, Uchiyama R, Ashida K, Maruo SJ, Terasawa K.

Heliyon. 2018 Dec 1;4(12):e00985. doi: 10.1016/j.heliyon.2018.e00985. eCollection 2018 Dec.

4.

The effectiveness of a Japanese style health program: comparison between Minowa, Japan and Rayong, Thailand.

Fujimori S, Maruo SJ, Piaseu N, Kalampakorn S, Sasimonthonkul S, Nakade K, Watanabe T, Murata Y, Sasamori F, Terasawa S, Okuhara M, Tabuchi H, Terasawa K.

Heliyon. 2018 Nov 26;4(11):e00961. doi: 10.1016/j.heliyon.2018.e00961. eCollection 2018 Nov.

5.

3D Shape Reconstruction of 3D Printed Transparent Microscopic Objects from Multiple Photographic Images Using Ultraviolet Illumination.

Koyama K, Takakura M, Furukawa T, Maruo S.

Micromachines (Basel). 2018 May 27;9(6). pii: E261. doi: 10.3390/mi9060261.

6.

Association of Decreased Handgrip Strength with Reduced Cortical Thickness in Japanese Female Patients with Type 2 Diabetes Mellitus.

Nakamura M, Inaba M, Yamada S, Ozaki E, Maruo S, Okuno S, Imanishi Y, Kuriyama N, Watanabe Y, Emoto M, Motoyama K.

Sci Rep. 2018 Jul 17;8(1):10767. doi: 10.1038/s41598-018-29061-x.

7.

Correlation analysis of monocyte subsets and insulin resistance considering fetuin-A involvement in patients with type 2 diabetes.

Maruo S, Mori K, Motoyama K, Nakamura M, Kawarabayashi R, Kakutani Y, Yamazaki Y, Morioka T, Shoji T, Inaba M, Emoto M.

Clin Transl Med. 2018 Mar 27;7(1):9. doi: 10.1186/s40169-018-0187-4.

8.

Positive association of plasma leptin with sleep quality in obese type 2 diabetes patients.

Hirota T, Morioka T, Yoda K, Toi N, Hayashi N, Maruo S, Yamazaki Y, Kurajoh M, Motoyama K, Yamada S, Shoji T, Emoto M, Inaba M.

J Diabetes Investig. 2018 Sep;9(5):1100-1105. doi: 10.1111/jdi.12826. Epub 2018 Mar 26.

9.

Spontaneous hair follicle germ (HFG) formation in vitro, enabling the large-scale production of HFGs for regenerative medicine.

Kageyama T, Yoshimura C, Myasnikova D, Kataoka K, Nittami T, Maruo S, Fukuda J.

Biomaterials. 2018 Feb;154:291-300. doi: 10.1016/j.biomaterials.2017.10.056. Epub 2017 Nov 6.

PMID:
29156398
10.

Development of a High-Density Microplasma Emission Source for a Micro Total Analysis System.

Kakegawa K, Harigane R, Aida M, Miyahara H, Maruo S, Okino A.

Anal Sci. 2017;33(4):505-510. doi: 10.2116/analsci.33.505.

11.

Predictive factors of rectal toxicity after permanent iodine-125 seed implantation: Prospective cohort study in 2339 patients.

Katayama N, Yorozu A, Maruo S, Kojima S, Ohashi T, Tanaka N, Kikuchi T, Higashide S, Saito S, Dokiya T, Fukushima M, Yamanaka H.

Brachytherapy. 2016 Nov - Dec;15(6):736-745. doi: 10.1016/j.brachy.2016.09.001. Epub 2016 Oct 6.

PMID:
27720311
12.

A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial.

Kamba T, Kamoto T, Maruo S, Kikuchi T, Shimizu Y, Namiki S, Fujimoto K, Kawanishi H, Sato F, Narita S, Satoh T, Saito H, Sugimoto M, Teishima J, Masumori N, Egawa S, Sakai H, Okada Y, Terachi T, Ogawa O; ZAPCA Study Group.

Int J Clin Oncol. 2017 Feb;22(1):166-173. doi: 10.1007/s10147-016-1037-2. Epub 2016 Sep 10.

PMID:
27614621
13.

Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study.

Nakano M, Yorozu A, Saito S, Sugawara A, Maruo S, Kojima S, Kikuchi T, Fukushima M, Dokiya T, Yamanaka H.

Radiat Oncol. 2015 Nov 14;10:228. doi: 10.1186/s13014-015-0532-3.

14.

The Effect of Multifactorial Intervention Programs on Health Behavior and Symptom Control Among Community-Dwelling Overweight Older Adults With Knee Osteoarthritis.

Saraboon Y, Aree-Ue S, Maruo SJ.

Orthop Nurs. 2015 Sep-Oct;34(5):296-308. doi: 10.1097/NOR.0000000000000180.

PMID:
26375841
15.

Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study.

Ohashi T, Yorozu A, Saito S, Tanaka N, Katayama N, Kojima S, Maruo S, Kikuchi T, Dokiya T, Fukushima M, Yamanaka H.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):141-9. doi: 10.1016/j.ijrobp.2015.05.014. Epub 2015 May 15.

PMID:
26279031
16.

[Trends in cohort effects of cardiovascular disease mortality in Japan, 1950-2010].

Maruo S, Iso H.

Nihon Koshu Eisei Zasshi. 2015;62(2):57-65. doi: 10.11236/jph.62.2_57. Japanese.

17.

Synovial plicae and temporomandibular joint disorders: surgical findings.

Murakami K, Hori S, Yamaguchi Y, Mercuri LG, Harayama N, Maruo S, Takahashi T.

J Oral Maxillofac Surg. 2015 May;73(5):827-33. doi: 10.1016/j.joms.2014.12.018. Epub 2014 Dec 24.

PMID:
25795190
18.

Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS).

Saito S, Ito K, Yorozu A, Aoki M, Koga H, Satoh T, Ohashi T, Shigematsu N, Maruo S, Kikuchi T, Kojima S, Dokiya T, Fukushima M, Yamanaka H.

Int J Clin Oncol. 2015 Apr;20(2):375-85. doi: 10.1007/s10147-014-0704-4. Epub 2014 May 21.

PMID:
24840041
19.

Anti-tumor effects of novel 5-O-acyl plumbagins based on the inhibition of mammalian DNA replicative polymerase activity.

Kawamura M, Kuriyama I, Maruo S, Kuramochi K, Tsubaki K, Yoshida H, Mizushina Y.

PLoS One. 2014 Feb 10;9(2):e88736. doi: 10.1371/journal.pone.0088736. eCollection 2014.

20.

Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.

Jiang S, Willox B, Zhou H, Holthaus AM, Wang A, Shi TT, Maruo S, Kharchenko PV, Johannsen EC, Kieff E, Zhao B.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):421-6. doi: 10.1073/pnas.1321704111. Epub 2013 Dec 16.

21.

Biomimetic synthesis of zeylanone and zeylanone epoxide by dimerization of 2-methyl-1,4-naphthoquinone.

Maruo S, Nishio K, Sasamori T, Tokitoh N, Kuramochi K, Tsubaki K.

Org Lett. 2013 Apr 5;15(7):1556-9. doi: 10.1021/ol400335s. Epub 2013 Mar 25.

PMID:
23527796
22.

EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes.

Katsumura KR, Maruo S, Takada K.

J Med Virol. 2012 Mar;84(3):504-10. doi: 10.1002/jmv.23208.

PMID:
22246839
23.

Replication of Epstein-Barr virus primary infection in human tonsil tissue explants.

Gotoh K, Ito Y, Maruo S, Takada K, Mizuno T, Teranishi M, Nakata S, Nakashima T, Iwata S, Goshima F, Nakamura S, Kimura H.

PLoS One. 2011;6(10):e25490. doi: 10.1371/journal.pone.0025490. Epub 2011 Oct 5.

24.

Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.

Maruo S, Kuriyama I, Kuramochi K, Tsubaki K, Yoshida H, Mizushina Y.

Bioorg Med Chem. 2011 Oct 1;19(19):5803-12. doi: 10.1016/j.bmc.2011.08.023. Epub 2011 Aug 18.

PMID:
21903399
25.

Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.

Maruo S, Zhao B, Johannsen E, Kieff E, Zou J, Takada K.

Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1919-24. doi: 10.1073/pnas.1019599108. Epub 2011 Jan 18.

26.

Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines.

Zhao B, Mar JC, Maruo S, Lee S, Gewurz BE, Johannsen E, Holton K, Rubio R, Takada K, Quackenbush J, Kieff E.

Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):337-42. doi: 10.1073/pnas.1017419108. Epub 2010 Dec 20.

27.

Optically driven micropump with a twin spiral microrotor.

Maruo S, Takaura A, Saito Y.

Opt Express. 2009 Oct 12;17(21):18525-32. doi: 10.1364/OE.17.018525.

PMID:
20372583
28.

Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.

Watanabe A, Maruo S, Ito T, Ito M, Katsumura KR, Takada K.

J Virol. 2010 Mar;84(6):2893-901. doi: 10.1128/JVI.01616-09. Epub 2009 Dec 30.

29.

EBNA3C interacts with Gadd34 and counteracts the unfolded protein response.

Garrido JL, Maruo S, Takada K, Rosendorff A.

Virol J. 2009 Dec 29;6:231. doi: 10.1186/1743-422X-6-231.

30.

Single-anchor support and supercritical CO2 drying enable high-precision microfabrication of three-dimensional structures.

Maruo S, Hasegawa T, Yoshimura N.

Opt Express. 2009 Nov 9;17(23):20945-51. doi: 10.1364/OE.17.020945.

PMID:
19997332
31.

Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.

Lee S, Sakakibara S, Maruo S, Zhao B, Calderwood MA, Holthaus AM, Lai CY, Takada K, Kieff E, Johannsen E.

J Virol. 2009 Dec;83(23):12368-77. doi: 10.1128/JVI.01403-09. Epub 2009 Sep 23.

32.

Quantitative evaluation of the role of Epstein-Barr virus immediate-early protein BZLF1 in B-cell transformation.

Katsumura KR, Maruo S, Wu Y, Kanda T, Takada K.

J Gen Virol. 2009 Oct;90(Pt 10):2331-41. doi: 10.1099/vir.0.012831-0. Epub 2009 Jun 24.

PMID:
19553389
33.

Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.

Maruo S, Wu Y, Ito T, Kanda T, Kieff ED, Takada K.

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4419-24. doi: 10.1073/pnas.0813134106. Epub 2009 Feb 23.

34.
35.

Multibeam scanning optics with single laser source for full-color printers.

Maruo S, Arimoto A, Kobayashi S.

Appl Opt. 1997 Oct 1;36(28):7234-8.

PMID:
18264232
36.

Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation.

Wu Y, Maruo S, Yajima M, Kanda T, Takada K.

J Virol. 2007 Oct;81(20):11236-45. Epub 2007 Aug 8.

37.

Symmetrical localization of extrachromosomally replicating viral genomes on sister chromatids.

Kanda T, Kamiya M, Maruo S, Iwakiri D, Takada K.

J Cell Sci. 2007 May 1;120(Pt 9):1529-39. Epub 2007 Apr 3.

38.

Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.

Maruo S, Wu Y, Ishikawa S, Kanda T, Iwakiri D, Takada K.

Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19500-5. Epub 2006 Dec 11.

39.
40.

[EBV and apoptosis].

Maruo S.

Nihon Rinsho. 2006 Mar;64 Suppl 3:576-9. Review. Japanese. No abstract available.

PMID:
16615537
41.

Tunicamycin decreases the probability of single-channel openings for N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors.

Maruo K, Yamamoto S, Kanno T, Yaguchi T, Maruo S, Yashiya S, Nishizaki T.

Neuroreport. 2006 Feb 27;17(3):313-7.

PMID:
16462604
42.

RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines.

Zhao B, Maruo S, Cooper A, R Chase M, Johannsen E, Kieff E, Cahir-McFarland E.

Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1900-5. Epub 2006 Jan 30.

43.
44.

Modulation of P2X receptors via adrenergic pathways in rat dorsal root ganglion neurons after sciatic nerve injury.

Maruo K, Yamamoto H, Yamamoto S, Nagata T, Fujikawa H, Kanno T, Yaguchi T, Maruo S, Yoshiya S, Nishizaki T.

Pain. 2006 Jan;120(1-2):106-12. Epub 2005 Dec 19.

PMID:
16360272
45.

Experimental study of neural repair of the transected spinal cord using peripheral nerve graft.

Fukunaga S, Sasaki S, Fu T, Yokoyama H, Lee I, Nakagaki I, Hori S, Tateishi H, Maruo S.

J Orthop Sci. 2004;9(6):605-12.

PMID:
16228679
46.
47.

Changes in the axonal membrane potential and Ca2+ concentration associated with peripheral nerve grafting after spinal cord injury.

Itohara H, Sasaki S, Fu T, Nakagaki I, Hori S, Tateishi H, Maruo S.

Jpn J Physiol. 2004 Aug;54(4):365-71.

PMID:
15631692
48.

Inhibition by interleukin-18 of the growth of Dunn osteosarcoma cells.

Okamoto T, Yamada N, Tsujimura T, Sugihara A, Nishizawa Y, Ueda H, Kashiwamura S, Tsutsui H, Futani H, Maruo S, Okamura H, Terada N.

J Interferon Cytokine Res. 2004 Mar;24(3):161-7.

PMID:
15035849
49.

Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes.

Hathout EH, Fujishige L, Geach J, Ischandar M, Maruo S, Mace JW.

Diabetes Technol Ther. 2003;5(5):801-6.

PMID:
14633345
50.

[Pheochromocytoma with ischemic enterocolitis].

Yamamoto N, Isotani H, Kamei K, Maruo S, Koma M, Sakaguchi H, Kitaoka H, Kimura F, Hanafusa T.

Nihon Naika Gakkai Zasshi. 2003 Aug 10;92(8):1534-6. Japanese. No abstract available.

PMID:
13677905

Supplemental Content

Support Center